Skip to main content
Clinical Trials/IRCT2013102915204N1
IRCT2013102915204N1
Completed
Phase 2

Determination of therapeutic efficacy of N-acetyl cysteine with the combination of N-acetyl cysteine and Cimetidine in acute acetaminophen toxicity

Vice chancellor for research, Mashhad University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Acute acetaminophen toxicity.
Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Enrollment
30
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • The inclusion major criteria to study, are: having para\-clinical acetaminophen toxicity (toxic acetaminophen serum levels), and referring to the emergency poisoning department of Imam Reza Hospital, less than 8 hours from the poisoning.
  • Exclusion major criteria from study, are as follows: having multiple toxicities; simultaneous diseases affecting the liver enzymes (e.g. heart failure, congenital liver defects, and hepatitis); recent (less than a week) or regular consumption of other drugs;Those patients who didn’t consent to the treatment, or were discharged from the hospital, were also excluded from the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials